Skip to main content icon/video/no-internet

The rat (Rattus norvegicus) is a widely used animal model. An animal model refers to a nonhuman animal used in the study of human diseases in order to gain a better understanding of the disease process without harming human beings. Animal disease-modeling allows for the study of biological mechanisms underlying disease and offer the opportunity to perform preclinical trials of new therapies. The use of animal models has played an important role in the development of drugs, treatments, and cures of countless human diseases. Although mice have been the most commonly used human disease model for many decades, the rat offers several advantages over the mouse and other organisms. Rats are more similar to humans in terms of physiological composition, cellular regulatory mechanisms, and intelligence level. Rat physiology is also easier to monitor and their smaller body size makes for easier handling and care. Furthermore, the rat is a more suitable model for complicated diseases, including cardiovascular diseases such as stroke and hypertension, as well as diseases of the nervous system such as Parkinson’s and Huntington’s disease. Presently, a number of rodent studies are being carried out on the transplantation of therapeutic stem cells. If preliminary studies with rodent stem cells are successful, then scientists will attempt to transplant stem cells into primates before progressing to human studies. Rats are increasingly being used for medical research, and the relatively recent successful isolation of rat embryonic stem cells has seen the rapid expansion of their utility in the field of stem cell research.

Rat Induced Pluripotent Stem Cells

The discovery of induced pluripotent stem cells (iPSCs) has been a massive breakthrough in stem cell research due to their enormous potential for developing novel therapeutic strategies.

Induced pluripotent stem cells are created by reprogramming specialized cells, such as skin cells, to give them the ability to turn into any cell type in the body (pluripotency). The generation of iPSCs was first reported in 2006 by a group that managed to successfully reprogram mouse somatic cells by the insertion of four genes using a viral vector. Induced pluripotent stem cells, for rats and other species for which embryonic stem cells have not been established or a difficult to isolate, could be an invaluable research tool. The generation of iPSCs from disease model rats is likely to provide an insight into the pathogenesis of broad range of disorders. The use of rat iPSCs (riPSCs) is still in its early stage and only a few studies have been published on their use and properties. In August 2014, researchers reported the establishment of rat model of metabolic syndrome (MetS), a condition that is characterized by diabetes, high blood pressure, and obesity. The technique used involved crossing Dahl salt-sensitive rats (DS/obese) with Zucker rats. The researchers produced riPSCs from mesenchymal stromal cells (MSCs) acquired from the fat cells of adult rats. The MSCs were treated with three reprogramming factors to convert them into pluripotent cells. These riPSCs exhibited the marker genes of embryonic stem cells and demonstrated a similar capacity for differentiation.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading